Eli Lilly logo

LLYEli Lilly

Pharma & Healthcare · US · Eli Lilly and Company

4 of 6 ratios computed · receipts verified server-side

Idiot Index
47
out of 100 · 4/6 ratios · FY 2023

The full receipt

Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.

  • Markup

    How much revenue per dollar of cost.

    3.8724× revenue / costverified
    $1 of cost becomes $3.87 of revenue
    Sector median: 3.1882Median range for extraction in sector
    FY 2023v1.0.0
  • Operational Markup

    Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.

    1.3697× revenue / (cost + opex)verified
    $1 of cost+opex becomes $1.37 of revenue
    Sector median: 1.2871Median range for extraction in sector
    FY 2023v1.0.0
  • Labor Share

    How much of every revenue dollar reaches workers.

    Not yet computed for this company.
  • Executive Extraction

    How many times a CEO out-earns the median employee.

    Not yet computed for this company.
  • Shareholder Extraction

    Dollars sent to shareholders for every dollar invested in R&D.

    0.6257× buybacks+dividends / R&Dverified
    $0.63 to shareholders per $1 in R&D — net reinvesting
    Sector median: 0.7492Median range for extraction in sector
    FY 2023v1.0.0
  • Capital Extraction

    How much of net profit goes to shareholders rather than back into the business.

    0.7770× buybacks+dividends / net incomeverified
    78% of net profit returned to shareholders, 22% reinvested
    Sector median: 0.5294Median range for extraction in sector
    FY 2023v1.0.0

Company response

No verified response yet. If you represent Eli Lilly, you can add context, agree, or dispute.

Source data

Every raw line item this company disclosed in its XBRL filings. Click any filing to view the original on SEC.gov.

FY 2023· 10 facts
ConceptValueUnitPeriodFilingReceipt
CEO Total Compensation
CEOTotalCompensation
0USDFY0000059478-24-000099verified
Cost of Goods Sold
CostOfGoodsAndServicesSold
7,312,800,000USDFY0000059478-24-000065verified
Dividends Paid
PaymentsOfDividends
3,086,800,000USDFY0000059478-24-000065verified
Median Employee Compensation
MedianEmployeeCompensation
0USDFY0000059478-24-000099verified
Net Income
NetIncomeLoss
5,581,700,000USDFY0000059478-24-000065verified
Operating Expenses
OperatingExpensesDerived(sum:SellingGeneralAndAdministrativeExpense+ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost)
13,362,300,000USDFY0000059478-24-000065verified
R&D Expense
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
6,930,700,000USDFY0000059478-24-000065verified
Revenue
Revenues
28,318,400,000USDFY0000059478-24-000065verified
Stock Buybacks
PaymentsForRepurchaseOfCommonStock
1,250,000,000USDFY0000059478-24-000065verified
Total Employee Count
TotalEmployees
23,000employeesFY0000059478-24-000065verified